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Intrinsically disordered proteins play important roles in mediating regulatory
interactions. While many of these proteins fold upon binding to targets, others
appear to be only transiently and locally ordered, existing in a dynamic com-
plex with protein partners. The interaction of the disordered Sic1 (a cyclin de-
pendent kinase inhibitor) with Cdc4 (a component of an SCF ubiquitin ligase)
involves the dynamic exchange of multiple linear binding motifs within Sic1 on
and off of a single Cdc4 binding site. The disordered nature of the Sic1 chain
enables Cdc4 to recognize multiply phosphorylated Sic1 by sensing a mean
electrostatic field rather than only the field due to local binding of a linear motif.
This sensitivity to multiple phosphorylations may facilitate a switch-like
biological response of Sic1 ubiquitination and degradation to cyclin kinase ac-
tivity. The regulatory (R) region of the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) is another example, with transient and local ordering of
multiple segments upon binding to multiple target proteins. The R region
dynamic complex with the first nucleotide binding domain (NBD1) of CFTR
appears to facilitate a rheostat-like function in activating CFTR channel con-
ductance with an ability to integrate multiple regulatory binding inputs. We
have measured NMR and SAXS structural data and used them as input to
our program ENSEMBLE to generate sets of coordinates that represent signif-
icantly populated conformers within the isolated disordered states of Sic1 and
the CFTR R region. The resulting ensembles can be docked to structures of the
folded binding domains to further enable characterization of these dynamic
complexes, leading to a better understanding of the role of disordered protein
interactions in biological regulation.
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Allosteric communications are important for cellular signaling1, including
ubiquitin systems. In E3 ubiquitin ligases, substrate binding proteins, e.g.
VHL-box, SOCS-box or the F-box proteins, recruit substrates for ubiquitina-
tion via conformational selection and population shift2,3, accurately position-
ing and orienting the substrates for ubiquitin transfer. Yet, how does the E3
machinery precisely position the substrate? What is the role of allostery in
regulation of signaling for ubiquitin or ubiquitin-like systems? To address
these questions, we performed molecular dynamics simulations for different
ubiquitin or ubiquitin-like systems. We simulated seven substrate binding
proteins. All have two domains: one binds to the substrate; the other to
E3 ligase modules Skp1/Elongin C. We found that in all cases the flexible
inter-domain linker serves as a hinge rotating the substrate binding domain,
optimally and accurately positioning it for ubiquitin transfer. We further ob-
served that the linker flexibility could be regulated allosterically by binding
events of either domain. For one of these substrate binding proteins, pVHL,
a tumor suppressor protein which forms part of the E3 ubiquitin ligase com-
plex and regulates the degradation of the hypoxia inducible factor, we de-
signed five allosterically-stabilizing mutants to stabilize the inter-domain in-
terface4. We proposed that drugs mimicking the mutants’ allosteric effects
may rescue pVHL function in the von Hippel-Lindau disease. Ubiquitin-
like E3 ligases are also observed to allosterically regulate degradation. Su-
moylation involves covalent attachment of SUMO (Small Ubiquitin-Like
Modifier) to target proteins. The E3 ligase, RanBP2, was observed to
allosterically regulate sumoylation process.
1. Tsai CJ, del Sol A, Nussinov R. J Mol Biol. 378:1-11, 2008.
2. Ma B, Kumar S, Tsai CJ, Nussinov R. Protein Eng. Des. Sel. 12:713-720,
1999.
3. Boehr DD, Wright PE. Science 320:1429-30, 2008.
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Multi-domain signaling proteins exhibit complex behaviors due to cooperative
interactions between domains. In many such proteins a core regulatory interac-
tion, involving binding of an inhibitory domain to the active site of a catalytic
domain, is cooperatively enhanced by additional intramolecular domain-
domain contacts. However, the physical basis of this cooperativity, and thus
the energetic construction of multi-domain systems, is not well understood.
The five-domain N-terminal regulatory element of the Vav1 proto-oncoprotein
is representative of this class of signaling molecules. The catalytic activity of
the Vav1 Dbl homology (DH) domain is autoinhibited by binding of an adjacent
helix into the enzyme active site. This core inhibitory process is cooperatively
enhanced through an unknown mechanism by intramolecular contacts of the
N-terminal calponin homology (CH) domain of the protein. Here we show by
NMR spectroscopy that the isolated helix-DH module exists in equilibrium be-
tween a ground state where the active site is blocked by the inhibitory helix, and
an excited state where the helix is dissociated. The rate of phosphorylation of the
helix, an event that relieves autoinhibition, is linearly related to the population
of the excited state. Thus, phosphorylation only occurs efficiently through
the excited state, and internal dynamics are required for and control the rate
of activation of the helix-DH module. In the full five-domain element this
regulatory equilibrium is further biased 10-20-fold toward the closed state, im-
plying that regulatory cooperativity derives from thermodynamic coupling be-
tween the helix-DH equilibrium and other interdomain binding equilibria in the
protein. This explains the transforming activity of truncated Vav1 proteins lack-
ing the CH domain, and suggests that Vav1 activation in vivo likely involves
integration of kinase signals and signals to the CH or other domains of the
molecule.Symposium 2: Many Ways to Regulate a
Molecular Motor
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Myosin-Is are the single-headed, membrane-associated members of the myosin
superfamily that are found in most eukaryotic cells. They have been shown to
play essential roles in membrane dynamics, cytoskeletal structure, mechanical
signal-transduction, endosome processing, and possibly nuclear transcription.
Unlike many other unconventional myosins, vertebrate myosin-Is are catalyti-
cally and mechanically active in the absence of post-translational modification,
bound cargo or accessory proteins, or other signaling molecules. Therefore, it
appears that recruitment of myosin-Is to specific cellular regions of high actin
concentration is all that is required for catalytic activation. However, once ac-
tivated, the kinetic activity of at least one isoform, myo1b, has been shown to
be dramatically regulated by tension. Using an optical trap, we found that the
rate of myo1b detachment from actin decreases>75-fold under tension of 2 pi-
conewtons or less, resulting in myo1b transitioning from a low (<0.2) to a high
(>0.9) duty-ratio motor. We are investigating the mechanism of this force reg-
ulation, and we are investigating the effects of these forces on the attachment of
myosin-I to lipid membranes.
17-Symp
Structural Basis for The Regulation of Drosophila Myosin 7a
James R. Sellers1, Yi Yang1, Thomas Baboolal2, Verl Siththanandan1,
Matthew L. Walker2, Peter J. Knight2, Michelle Peckham2.
1National Heart, Lung and Blood Institute, Bethesda, MD, USA, 2University
of Leeds, Leeds, United Kingdom.
Drosophila myosin-7a is a single-headed myosin with a tail containing two
MyTH4-FERM domains separated by an SH3 domain. Myosin-7a is often
found in regions of high actin density and mutations in human myosin-7a result
in deafness and blindness.We have previously shown that a subfragment-1 (S1)
from this myosin has a Vmax of 1s-1 and a KATPase of 1mM. Full length my-
osin-7a has a Vmax similar to that of S1, but its KATPase is about 30mM. Neg-
atively-stained processed images of myosin-7a in the presence of ATP show
that the tail is tightly folded back against the motor domain forming a compact
structure which obscures the normally easily recognized features of the motor
4a Sunday, March 1, 2009domain. Myosin-7a unfolds at either high ionic strength or in the absence of
ATP, revealing a clearly recognizable motor domain, the lever arm and some
features of the tail region. C-terminal truncations were made to determine
which portions of the multi-domained tail are necessary for the regulation. Re-
moval of the last 99 amino acids which are highly conserved in all myosin-7a
molecules and form a subdomain (termed MyTH7) of the FERM domain, or
mutation of two conserved amino acids in this region, is sufficient to prevent
folding of the molecule in the presence of ATP and activates the enzymatic ac-
tivity. A construct consisting of the second FERM domain binds actin in an
ATP-insensitive manner with a Kd of 30mM which is similar to the KATPase
value for the full length molecule. We propose that at low actin concentration
myosin-7a is folded and inactive, but at high actin concentrations such exists in
actin bundles, it binds first via its tail binding site which then frees the motor
domain to functionally interact with actin.
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The Ups and Downs of Smooth Muscle Myosin Regulation
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Since discovery that regulatory light chain (RLC) phosphorylation was the pri-
marymethod of regulation of smooth and non-muscle myosin II, the structure of
the phosphorylated and dephosphorylated forms has been a goal only partially
realized. Regulation in both smooth muscle and the related scallop striated mus-
clemyosin requires a 2-headedmyosin species; single headed species are unreg-
ulated. Thus head to head interactions are key to achieving the inhibited state. A
folded conformation of full length myosin, generally referred to as the 10S con-
formation was discovered early by conventional electron microscopy and in
1999, a structural explanation for the head-head interactions was obtained
from2-D arrays of dephosphorylated smoothmuscle heavymeromyosin formed
on lipid monolayers and imaged in 3-D by cryoEM. The structure was later con-
firmed by 2-D arrays of the 10S conformation of wholemyosin.While this struc-
ture explained inhibition of the solubilized form of regulated myosins, it had not
been observed in filaments. Surprisingly, the first observation of smooth muscle
myosin-like head-head interactions in a thick filament was obtained from taran-
tula striatedmuscle, not from smooth muscle myosin. Evenmore surprising was
the observation of a similar conformation in relaxed cardiac muscle thick fila-
ments. Thus, these head-head interactions observed first in smooth muscle
HMM, appear to be ubiquitous in relaxed muscle although still not confirmed
for thick filaments in relaxed smooth muscle. Still to be determined is an expla-
nation of the factors that can lead to solubilization and the location of the N-ter-
minus of the RLC, whose location and structure has yet to be revealed, in the
phosphorylated and dephosphorylated state. Theoretical modeling has provided
possible explanations for several factors that affect regulation but has not yet
yielded a coherent theory. Supported by NIAMSD.
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Myosin binding protein-C (MyBP-C) is a thick-filament protein in vertebrate
sarcomeres that limits cross-bridge cycling kinetics and reduces myocyte power
output. However, the mechanisms by which MyBP-C influences cross-bridge
kinetics are not well understood. The goal of the present study was to investi-
gate the ability of the first 4 N-terminal domains (C0-C1-motif-C2) of cardiac
(c) MyBP-C to affect actomyosin interactions and interact with actin. Here we
show that recombinant proteins containing the C1 and motif domains increased
Ca2þ sensitivity of tension and increased rates of tension redevelopment (ktr) at
submaximal [Ca2þ] in permeabilized rat trabeculae. Proteins containing these
domains also biphasically activated then inhibited Ca2þ-activated ATPase rates
of heavy meromyosin and myosin S1 in solution. Cosedimentation binding
assays demonstrated saturable binding of the 4 N-terminal domains to F-actin
at a 1:1 molar ratio (Kd ~ 10mM). However, more than one interaction site was
indicated by turbidity and electron microscope analyses that showed actin bun-
dling in the presence of recombinant proteins. Phosphorylation of the motif
or increasing pH reduced binding to a 1:2 molar ratio and abolished actin bun-
dling. Phosphorylation reduced but did not eliminate effects of recombinant
proteins to increase Ca2þ sensitivity of tension and ktr at submaximal [Ca
2þ]
in permeabilized trabeculae. Together these results suggest that the N-terminus
of cMyBP-C interacts with F-actin through multiple distinct sites, at least one
site is modulated by electrostatic charge interactions, and that functional effects
of the N-terminus of MyBP-C are mediated in part by phosphorylation indepen-
dent mechanisms. Supported by NIH HL080367.Platform A: Protein Conformation
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Active Unfolding of Collagen is not Required for Collagenolysis to Occur
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Ramon Salsas-Escat, Collin M. Stultz.
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A number of disorders such as tumor metastasis, arthritis, and atherosclerotic
heart disease are related to excessive collagen degradation. Therefore methods
that further our understanding of collagenolysis are of particular interest.
However, as the collagenase active site is too small to accommodate the tri-
ple-helical structure of collagen and the scissile bond within collagen is not
accessible to the collagenase catalytic site, the precise molecular mechanism
of collagenolysis is unclear. Prior experiments have been interpreted to mean
that collagenases actively unfold collagen, in a process that requires intact
full length collagenase - which is typically a multi-domain protein, containing
both a catalytic and hemopexin-like domain - leading to exposure of the scissile
bond. Here we demonstrate that collagen types I and III can be degraded by the
catalytic domain alone of either MMP1 or MMP8 at temperatures far below the
melting temperature of collagen. These data argue that active unwinding of col-
lagen is not required for collagenolysis to occur in solution.Molecular simulations
further suggest that normal thermal fluctuations in the structure of the triple-heli-
cal structure of collagen lead to the protein sampling stateswhere the scissile bond
is relatively exposed and hence accessible to collagenase active site. Taken to-
gether, these data suggest that collagen degradation is the result of the interaction
of preformed locally unfolded states of collagen and collagenases, rather than
a mechanism that involves active collagenase-mediated unfolding.
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While nanoparticles have been studied and used for many years and their
unique chemical and physical properties have been extensively characterized,
nanoparticles are now increasingly used to investigate biological systems.
Nanoparticles can be formed on a submicron scale and do not interfere with
normal biological processes, thus can be used in an in vivo system, allowing
researchers to gain insight into its inner workings. The use of nanoparticles
has also proven to be quite flexible, and has provided an indispensable tool
in the advancement of drug delivery, tissue engineering, and detection of bio-
molecules. We have previously studied conformational changes occuring
within proteins upon binding to phospholipid model membranes, particularly
the tumor suppressor protein PTEN. To gain a more in depth characterization
of these protein conformation changes, we have developed a technique in
which we have fabricated 50nm gold nanoparticles coated with an asymmetric
lipid bilayer, in a manner that allows us to control the identity of the lipids mak-
ing up the outer leaflet. Using Raman spectroscopy, we will take advantage of
the surface enhanced Raman spectroscopy (SERS) effect, which will increase
PTEN band intensities binding of the protein to the lipid covered nanoparticle.
Systematic mutation of tryptophan residues within the protein will allow us to
probe the binding induced conformational changes in the vicinity of the tryp-
tophan. While SERS has been used previously to study protein conformational
changes, proteins were in these cases directly immobilized onto the nanopar-
ticles. In contrast, our novel approach immobilizes the lipids on the nanopar-
ticles and the protein can freely interact with the target lipid. While we plan
to use these methods to examine PTEN, further development of this technique
will allow for better study of conformational changes in a myriad of interfacial
enzymes.
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Spectroscopic evidence for the presence of local order in unfolded proteins, in-
cluding polyproline II (PII) structure, now appears incontrovertible. The data
supporting this order relies on analysis of short chain peptides. The dimensions
of unfolded chains nevertheless conform to random coils. We have re-exam-
ined the dimensional properties of short chains using paramagnetic proton
spin relaxation measurements to evaluate intermediate range distances (r)
